Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (61-70 of 563) with videos related to

Pageof 57
Sort By:
Current Treatment Options in Cardiovascular Medicine|March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation CarriersKelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2021
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysisKaren A Gelmon, Peter A Fasching, Fergus J Couch, et al.
JCO Precision Oncology|June 24, 2025
Epithelial Abnormalities in the High-Risk Fallopian Tube of a Rare <i>TP53</i>/<i>BRCA2</i> Li-Fraumeni Syndrome Patient With Multiple TumorsMegan L Ritting, Simrit K Warring, Manuel M Bettencourt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
Human Mutation|October 13, 2011
Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVsMaxime P Vallée, Tiana C Francy, Megan K Judkins, et al.
Cancer Research|August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinomaWataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
JCO Precision Oncology|September 14, 2020
Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical OutcomeSiddhartha Yadav, Steven N Hart, Chunling Hu, et al.
Clinical Breast Cancer|October 4, 2024
Madarosis Among Breast Cancer SurvivorsSarah K Premji, Kathryn J Ruddy, Nicole Larson, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Oncogene|January 13, 2004
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancerJeremy Chien, Julie Staub, Shou-Ih Hu, et al.
Pageof 57

Showing results (61-70 of 563) with videos related to

Sort By:
Pageof 57
Current Treatment Options in Cardiovascular Medicine|March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation CarriersKelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2021
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysisKaren A Gelmon, Peter A Fasching, Fergus J Couch, et al.
JCO Precision Oncology|June 24, 2025
Epithelial Abnormalities in the High-Risk Fallopian Tube of a Rare <i>TP53</i>/<i>BRCA2</i> Li-Fraumeni Syndrome Patient With Multiple TumorsMegan L Ritting, Simrit K Warring, Manuel M Bettencourt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
Human Mutation|October 13, 2011
Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVsMaxime P Vallée, Tiana C Francy, Megan K Judkins, et al.
Cancer Research|August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinomaWataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
JCO Precision Oncology|September 14, 2020
Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical OutcomeSiddhartha Yadav, Steven N Hart, Chunling Hu, et al.
Clinical Breast Cancer|October 4, 2024
Madarosis Among Breast Cancer SurvivorsSarah K Premji, Kathryn J Ruddy, Nicole Larson, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Oncogene|January 13, 2004
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancerJeremy Chien, Julie Staub, Shou-Ih Hu, et al.
Pageof 57